Glaucoma [clinicaltrials_resource:6f13a81eedf35468a19c389928ea9b91]
Fluorouracil Filtering Surgery Study (FFSS) [clinicaltrials:NCT00000122]clinicaltrials:NCT00000125Advanced Glaucoma Intervention Study (AGIS) [clinicaltrials:NCT00000148]Pigment Dispersion Syndrome With and Without Glaucoma [clinicaltrials:NCT00001152]Cause of Pigment Dispersion Syndrome [clinicaltrials:NCT00005919]Mechanism of Action of TRAVATAN 0.004% in Subjects With Glaucoma or Ocular Hypertension [clinicaltrials:NCT00061503]Safety and Efficacy Study of BETAXON 0.5% and AZOPT 1.0% in Pediatric Patients With Glaucoma or Ocular Hypertension [clinicaltrials:NCT00061516]Safety and Efficacy Study of BETOPTIC S 0.25% and Timolol Gel-Forming Solution 0.25% and 0.5% in Pediatric Patients With Glaucoma or Ocular Hypertension. [clinicaltrials:NCT00061542]Comparison of the Effects of Two Glaucoma Drugs Over 24 Hours (0507A-137)(COMPLETED) [clinicaltrials:NCT00108017]Evaluation Of Intraocular Pressure Lowering-Effect Of Xalacom In Patients With Poag Or Oh. [clinicaltrials:NCT00143208]SOLX Titanium Sapphire Laser for Trabeculoplasty [clinicaltrials:NCT00145535]Ocular Blood Flow in Early Glaucoma Patients Before and After Treatment With Dorzolamide [clinicaltrials:NCT00152932]The Genetic Study of Primary Angle-Closure Glaucoma [clinicaltrials:NCT00155857]Safety and Efficacy of Brimonidine in Patients With Glaucoma or Ocular Hypertension [clinicaltrials:NCT00168363]The Results of Ahmed Valve Operations [clinicaltrials:NCT00193960]clinicaltrials:NCT00224289Post-Operative Sub-Tenon Kenalog in Glaucoma Filtering Surgery [clinicaltrials:NCT00238563]The Canadian Glaucoma Study [clinicaltrials:NCT00262626]Clinical and Molecular Studies in Families With Glaucoma and Related Diseases [clinicaltrials:NCT00272363]Combined Phacotube vs Phacotrabeculectomy:A Randomized Controlled Trial [clinicaltrials:NCT00273221]Effects of Common Topical Glaucoma Therapy on Optic Nerve Head Blood Flow Autoregulation During Increased Arterial Blood Pressure and Artificially Elevated Intraocular Pressure in Healthy Humans [clinicaltrials:NCT00275756]Ultrasonic Evaluation of Ocular Tissues [clinicaltrials:NCT00279695]Novel Diagnostics for Ocular Structure [clinicaltrials:NCT00286637]Compliance and Administration Technique in Topical Drug Therapy of Glaucoma [clinicaltrials:NCT00303121]Assessment of the Ability to Distinguish Odors in Glaucoma Patients [clinicaltrials:NCT00304824]Tube Versus Trabeculectomy (TVT) Study [clinicaltrials:NCT00306852]Polymorphisms in the Human Matrix Metalloproteinase Genes MMP1, MMP3, and MMP9: Genetic Risk Factors of Primary Open Angle Glaucoma? [clinicaltrials:NCT00312403]Obstructive Sleep Apnea Syndrome in Glaucoma [clinicaltrials:NCT00313092]Ologen (OculusGen)-Glaucoma and Pterygium Historical Control Study in China Beijing Hospital [clinicaltrials:NCT00320762]Ologen (OculusGen)-Glaucoma and Pterygium Historical Control Study in Beijing Remin Hospital [clinicaltrials:NCT00321035]Analysis of Clinical Profiles of Chinese Patients With Normal Tension Glaucoma [clinicaltrials:NCT00321386]Psychopathology of Normal-tension Glaucoma in Hong Kong Chinese Out-patient [clinicaltrials:NCT00324181]Cellular Proteome From Leukocytes of Glaucoma Patients in Comparison With Patients With Parkinson's Disease [clinicaltrials:NCT00327301]mRNA Expression in Lymphocytes of Glaucoma Patients [clinicaltrials:NCT00327509]Plasma Levels of Matrix Metalloproteinases (MMPs) and Degree of DNA Fragmentation in Pseudoexfoliation (PEX) Glaucoma [clinicaltrials:NCT00327613]Optic Nerve Compliance Study [clinicaltrials:NCT00328835]An Evaluation of Use of Topical Ocular Hypotensive Medication by Compliance [clinicaltrials:NCT00329095]A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension [clinicaltrials:NCT00333125]Adult Providing Access to the Visual Environment (PAVE) - Glaucoma Pilot [clinicaltrials:NCT00338208]Endoscopic Goniotomy for Infantile Glaucoma [clinicaltrials:NCT00338533]
condition [clinicaltrials_vocabulary:condition]
Early Manifest Glaucoma Trial (EMGT) [clinicaltrials:NCT00000132]Glaucoma Laser Trial (GLT) Glaucoma Laser Trial Followup Study (GLTFS) [clinicaltrials:NCT00000144]Advanced Glaucoma Intervention Study (AGIS) [clinicaltrials:NCT00000148]Collaborative Initial Glaucoma Treatment Study (CIGTS) [clinicaltrials:NCT00000149]Pigment Dispersion Syndrome With and Without Glaucoma [clinicaltrials:NCT00001152]Abnormalities of the Eye's Anterior Chamber, Iris, Cornea and Lens [clinicaltrials:NCT00001161]Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-01-69 [clinicaltrials:NCT00047515]Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-02-41 [clinicaltrials:NCT00047528]Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-01-70 [clinicaltrials:NCT00047541]Phase 3 Study Comparing IOP Lowering in OAG or OH in Japanese Subjects C-01-98 [clinicaltrials:NCT00047593]Phase 4 Study Comparing IOP Lowering in OAG or OH in Caucasian or Japanese Subjects C-02-32 [clinicaltrials:NCT00047606]A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Open-Angle Glaucoma (OAG) or Ocular Hypertension (OHT) [clinicaltrials:NCT00051142]A 6-Week Safety and Efficacy Study of Travatan Compared to Xalcom in Subjects With Open-Angle Glaucoma(OAG) or Ocular Hypertension(OHT) [clinicaltrials:NCT00051155]A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Chronic Angle-Closure Glaucoma [clinicaltrials:NCT00051181]A 6-week Safety & Efficacy Study of Combination Intraocular Pressure-lowering Therapy in Patients With Open-angle Glaucoma or Ocular Hypertension [clinicaltrials:NCT00051194]Mechanism of Action of TRAVATAN 0.004% in Subjects With Glaucoma or Ocular Hypertension [clinicaltrials:NCT00061503]Safety and Efficacy Study of BETAXON 0.5% and AZOPT 1.0% in Pediatric Patients With Glaucoma or Ocular Hypertension [clinicaltrials:NCT00061516]A Phase III Study of Brimonidine Tartrate Ophthalmic Solution, 0.15% in Patients With Open-Angle Glaucoma or Ocular Hypertension [clinicaltrials:NCT00061529]Safety and Efficacy Study of BETOPTIC S 0.25% and Timolol Gel-Forming Solution 0.25% and 0.5% in Pediatric Patients With Glaucoma or Ocular Hypertension. [clinicaltrials:NCT00061542]Phase II Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-angle Glaucoma or Ocular Hypertension Patients [clinicaltrials:NCT00069706]Phase II Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-Angle Glaucoma or Ocular Hypertension Patients [clinicaltrials:NCT00069719]Comparison of the Effects of Two Glaucoma Drugs Over 24 Hours (0507A-137)(COMPLETED) [clinicaltrials:NCT00108017]A 12week, Randomized, Evaluator-Masked, Parallel Group Comparing Evening Dosing Of Xalacom Vs Cosopt In Subj W/ Glaucoma [clinicaltrials:NCT00140049]Efficacy And Safety Of Xalatan Compared To Usual Care In Patients With Open Angle Glaucoma Or Ocular Hypertension. [clinicaltrials:NCT00140062]Memantine in Patients With Chronic Glaucoma [clinicaltrials:NCT00141882]SOLX Titanium Sapphire Laser for Trabeculoplasty [clinicaltrials:NCT00145535]A 5-Year Postmarketing Safety Study Of Xalcom In Patients With Open Angle Glaucoma Or Ocular Hypertension [clinicaltrials:NCT00150267]Ocular Blood Flow in Early Glaucoma Patients Before and After Treatment With Dorzolamide [clinicaltrials:NCT00152932]The Genetic Study of Primary Angle-Closure Glaucoma [clinicaltrials:NCT00155857]A 12-Week, Randomized, Double-Masked, Parallel Group Comparison Of Evening Dosing With Xalacom In Subjects With Glaucoma [clinicaltrials:NCT00159653]Memantine in Patients With Chronic Glaucoma [clinicaltrials:NCT00168350]Safety and Efficacy of Brimonidine in Patients With Glaucoma or Ocular Hypertension [clinicaltrials:NCT00168363]Magnetic Resonance Imaging of Patients With Normal Tension Glaucoma [clinicaltrials:NCT00175786]The Results of Ahmed Valve Operations [clinicaltrials:NCT00193960]Xalacom And Combination Of Unfixed Latanoprost And Timolol In Subjects With Open-Angle Glaucoma Or Ocular Hypertension [clinicaltrials:NCT00219596]Diagnostic Innovations in Glaucoma Study [clinicaltrials:NCT00221897]African Descent and Glaucoma Evaluation Study [clinicaltrials:NCT00221923]clinicaltrials:NCT00224289Determination Of Predictive Factors Allowing To An Additional 10% Reduction Of Intra-Ocular Pressure [clinicaltrials:NCT00230763]Post-Operative Sub-Tenon Kenalog in Glaucoma Filtering Surgery [clinicaltrials:NCT00238563]
condition browse [clinicaltrials_vocabulary:condition-browse]
Early Manifest Glaucoma Trial (EMGT) [clinicaltrials:NCT00000132]Glaucoma Laser Trial (GLT) Glaucoma Laser Trial Followup Study (GLTFS) [clinicaltrials:NCT00000144]Advanced Glaucoma Intervention Study (AGIS) [clinicaltrials:NCT00000148]Collaborative Initial Glaucoma Treatment Study (CIGTS) [clinicaltrials:NCT00000149]Pigment Dispersion Syndrome With and Without Glaucoma [clinicaltrials:NCT00001152]Abnormalities of the Eye's Anterior Chamber, Iris, Cornea and Lens [clinicaltrials:NCT00001161]Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-01-69 [clinicaltrials:NCT00047515]Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-02-41 [clinicaltrials:NCT00047528]Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-01-70 [clinicaltrials:NCT00047541]Phase 3 Study Comparing IOP Lowering in OAG or OH in Japanese Subjects C-01-98 [clinicaltrials:NCT00047593]Phase 4 Study Comparing IOP Lowering in OAG or OH in Caucasian or Japanese Subjects C-02-32 [clinicaltrials:NCT00047606]A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Open-Angle Glaucoma (OAG) or Ocular Hypertension (OHT) [clinicaltrials:NCT00051142]A 6-Week Safety and Efficacy Study of Travatan Compared to Xalcom in Subjects With Open-Angle Glaucoma(OAG) or Ocular Hypertension(OHT) [clinicaltrials:NCT00051155]A Safety and Efficacy Study of Travoprost 0.004% Compared to Latanoprost 0.005% in Patients With Chronic Angle-Closure Glaucoma [clinicaltrials:NCT00051181]A 6-week Safety & Efficacy Study of Combination Intraocular Pressure-lowering Therapy in Patients With Open-angle Glaucoma or Ocular Hypertension [clinicaltrials:NCT00051194]Mechanism of Action of TRAVATAN 0.004% in Subjects With Glaucoma or Ocular Hypertension [clinicaltrials:NCT00061503]Safety and Efficacy Study of BETAXON 0.5% and AZOPT 1.0% in Pediatric Patients With Glaucoma or Ocular Hypertension [clinicaltrials:NCT00061516]A Phase III Study of Brimonidine Tartrate Ophthalmic Solution, 0.15% in Patients With Open-Angle Glaucoma or Ocular Hypertension [clinicaltrials:NCT00061529]Safety and Efficacy Study of BETOPTIC S 0.25% and Timolol Gel-Forming Solution 0.25% and 0.5% in Pediatric Patients With Glaucoma or Ocular Hypertension. [clinicaltrials:NCT00061542]Phase II Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-angle Glaucoma or Ocular Hypertension Patients [clinicaltrials:NCT00069706]Phase II Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-Angle Glaucoma or Ocular Hypertension Patients [clinicaltrials:NCT00069719]Comparison of the Effects of Two Glaucoma Drugs Over 24 Hours (0507A-137)(COMPLETED) [clinicaltrials:NCT00108017]A 12week, Randomized, Evaluator-Masked, Parallel Group Comparing Evening Dosing Of Xalacom Vs Cosopt In Subj W/ Glaucoma [clinicaltrials:NCT00140049]Efficacy And Safety Of Xalatan Compared To Usual Care In Patients With Open Angle Glaucoma Or Ocular Hypertension. [clinicaltrials:NCT00140062]Memantine in Patients With Chronic Glaucoma [clinicaltrials:NCT00141882]SOLX Titanium Sapphire Laser for Trabeculoplasty [clinicaltrials:NCT00145535]A 5-Year Postmarketing Safety Study Of Xalcom In Patients With Open Angle Glaucoma Or Ocular Hypertension [clinicaltrials:NCT00150267]Ocular Blood Flow in Early Glaucoma Patients Before and After Treatment With Dorzolamide [clinicaltrials:NCT00152932]The Genetic Study of Primary Angle-Closure Glaucoma [clinicaltrials:NCT00155857]A 12-Week, Randomized, Double-Masked, Parallel Group Comparison Of Evening Dosing With Xalacom In Subjects With Glaucoma [clinicaltrials:NCT00159653]Memantine in Patients With Chronic Glaucoma [clinicaltrials:NCT00168350]Safety and Efficacy of Brimonidine in Patients With Glaucoma or Ocular Hypertension [clinicaltrials:NCT00168363]Magnetic Resonance Imaging of Patients With Normal Tension Glaucoma [clinicaltrials:NCT00175786]The Results of Ahmed Valve Operations [clinicaltrials:NCT00193960]Xalacom And Combination Of Unfixed Latanoprost And Timolol In Subjects With Open-Angle Glaucoma Or Ocular Hypertension [clinicaltrials:NCT00219596]Diagnostic Innovations in Glaucoma Study [clinicaltrials:NCT00221897]African Descent and Glaucoma Evaluation Study [clinicaltrials:NCT00221923]clinicaltrials:NCT00224289Determination Of Predictive Factors Allowing To An Additional 10% Reduction Of Intra-Ocular Pressure [clinicaltrials:NCT00230763]Post-Operative Sub-Tenon Kenalog in Glaucoma Filtering Surgery [clinicaltrials:NCT00238563]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
eligibility for clinicaltrials:NCT01021657 [clinicaltrials_resource:1881982a0c46a1fe2cee19fe001e4ec8]eligibility for clinicaltrials:NCT00338013 [clinicaltrials_resource:9de17262b40556dae0de13be4459370a]eligibility for clinicaltrials:NCT00429819 [clinicaltrials_resource:ce32e373f6ef8c8f6d7618cd4ddb5139]eligibility for clinicaltrials:NCT01542710 [clinicaltrials_resource:e34f1189311adaff2327e0febdf788d7]eligibility for clinicaltrials:NCT00382226 [clinicaltrials_resource:f11e8f8f983b00ed2f6c272666f4f062]
exclusion criteria [clinicaltrials_vocabulary:exclusion-criteria]
eligibility for clinicaltrials:NCT01021657 [clinicaltrials_resource:1881982a0c46a1fe2cee19fe001e4ec8]eligibility for clinicaltrials:NCT00999973 [clinicaltrials_resource:62f8bde2b41354bf62f1089391c55f39]eligibility for clinicaltrials:NCT00338013 [clinicaltrials_resource:9de17262b40556dae0de13be4459370a]eligibility for clinicaltrials:NCT00429819 [clinicaltrials_resource:ce32e373f6ef8c8f6d7618cd4ddb5139]eligibility for clinicaltrials:NCT01542710 [clinicaltrials_resource:e34f1189311adaff2327e0febdf788d7]eligibility for clinicaltrials:NCT00382226 [clinicaltrials_resource:f11e8f8f983b00ed2f6c272666f4f062]
inclusion criteria [clinicaltrials_vocabulary:inclusion-criteria]
Glaucoma [clinicaltrials_resource:6f13a81eedf35468a19c389928ea9b91]
Bio2RDF identifier
6f13a81eedf35468a19c389928ea9b91
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:6f13a81eedf35468a19c389928ea9b91
identifier
clinicaltrials_resource:6f13a81eedf35468a19c389928ea9b91
title
Glaucoma
@en
type
label
Glaucoma [clinicaltrials_resource:6f13a81eedf35468a19c389928ea9b91]
@en